Ars Pharmaceuticals, Inc. · NASDAQ:SPRY
BlackRock, Inc.'s stake in Ars Pharmaceuticals, Inc. fell to 4.98% (Schedule 13G/A)
Event Mar 31, 2026 · Filed Apr 27, 2026
BlackRock, Inc.'s stake in Ars Pharmaceuticals, Inc. fell to 4.98%, 4,946,412 shares, as a passive investor on Mar 31, 2026. Filed Apr 27, 2026 (Schedule 13G/A).
- Stake
- 4.98%
- Shares
- 4,946,412
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 4.98% | 4,946,412 |
Source
Related
- Ars Pharmaceuticals, Inc.
- BlackRock, Inc.
- Ars Pharmaceuticals, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G · BlackRock, Inc. · Jan 21, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 14, 2026
- Form 4 · Karas Eric · Jun 12, 2026
- Form 4 · Fitzpatrick Alexander A · Jun 12, 2026
- Schedule 13G/A · Rubric Capital Management LP · May 15, 2026
- Schedule 13G/A · Millennium Management LLC · Mar 31, 2026